TMO vs IDXX — Key Metrics

Metric TMO (THERMO FISHER SCIENTIFIC INC) IDXX (IDEXX LABORATORIES INC)
Price692.74698.47
Market Cap256.67 Billion55.03 Billion
P/E (TTM)36.4846.81
P/B (Quarterly)4.71628.31
P/S (TTM)5.4211.8
Net Profit Margin (TTM)14.925.4
Gross Margin (TTM)41.162.7
ROE (TTM)13.371.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

THERMO FISHER SCIENTIFIC INC
vs
 
IDEXX LABORATORIES INC
 
THERMO FISHER SCIENTIFIC INC
vs
 
IDEXX LABORATORIES INC
Performance Comparison
AI Model Recommendation
TMO · THERMO FISHER SCIENTIFIC INC

Greatly Underperform

-67
UnderperformOutperform
IDXX · IDEXX LABORATORIES INC

Greatly Underperform

-98
UnderperformOutperform
Recommendation Summary

Both stocks are projected to greatly underperform the market over the next year. If you have to make a choice, Upfront Recommendation: TMO.

Financial Metrics
Prices delayed ~15 min
TMO Metrics IDXX
$692.74 Price $698.47
— Market Capitalization —
36.48 Price to Earnings Ratio 46.81
5.42 Price to Sales 11.8
33.61 Price to FCF Ratio 42.65
13.19 Price to Gross Profit 18.82
182.81 Price to R&D 206.21
10.02 Price to Current Assets 36.69

TMO vs IDXX at a glance

Thermo Fisher Scientific INC (TMO) and Idexx Laboratories INC (IDXX) are both Diagnostics & Research companies in the Healthcare sector. TMO is the larger, at $256.7 billion in market value against $55.0 billion for IDXX, about 4.7 times the size.

On trailing-twelve-month figures, TMO trades at 36.5 times trailing earnings and IDXX at 46.8; net profit margins are 14.9% and 25.4%.

The Upfront Investment model currently rates both Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.